Camilla Salvestrini Selected Research

Camilla Salvestrini Research Topics

2	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 02/2009 - 01/2008
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Atrophy 01/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2010
1	Eosinophilia 08/2009
1	Juvenile polyposis syndrome 05/2009
1	Protein-Energy Malnutrition (Marasmus) 02/2009
1	Communicable Diseases (Infectious Diseases) 02/2009
1	Edema (Dropsy) 02/2009
1	Inflammation (Inflammations) 02/2009
1	Kwashiorkor 02/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2009
1	Malnutrition (Nutritional Deficiencies) 02/2009
1	Skin Diseases (Skin Disease) 11/2008
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2008
1	Epidermolysis bullosa with pyloric atresia 11/2008
1	Hypertension (High Blood Pressure) 01/2008

2	Syndecan-1 (Syndecan 1)IBA 01/2014 - 02/2009
2	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 02/2009 - 01/2008
1	LipidsIBA 01/2022
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	SyndecansIBA 01/2014
1	beta-DefensinsIBA 10/2010
1	Immunoglobulin E (IgE)IBA 08/2009
1	Meloxicam (Mobic)FDA LinkGeneric 05/2009
1	GlycosaminoglycansIBA 02/2009
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2009
1	HLA-DR Antigens (HLA-DR)IBA 02/2009
1	A73025IBA 02/2009
1	Proteins (Proteins, Gene)FDA Link 02/2009
1	Biomarkers (Surrogate Marker)IBA 02/2009
1	Integrin beta4IBA 11/2008
1	IntegrinsIBA 11/2008
1	Blood Proteins (Serum Proteins)IBA 01/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008

1	Immunomodulation 11/2008